# Thermo Fisher Scientific Inc.  Share Price Target ‘$592.44’, now 7.3% Upside Potential

- Link: https://www.directorstalkinterviews.com/thermo-fisher-scientific-inc.share-price-target-592.44-now-7.3-upside-potential/4121142068
- Published: 2024-02-09T14:32:36+00:00
- Author: Charlotte Edwards

**Thermo Fisher Scientific Inc.** which can be found using ticker (TMO) have now
23 analysts in total covering the stock. The consensus rating is pointing to ‘buy’.
The range between the high target price and low target price is between $650.00 
and $520.00 calculating the average target share price we see $592.44. (at the time
of writing). Now with the previous closing price of $552.31 this is indicating there
is a potential upside of 7.3%. Also worth taking note is the 50 day moving average
now sits at $529.64 and the 200 day MA is $517.97. The market cap for the company
is 212.85B. The current share price for the company is: $550.89 USD

 The potential market cap would be $228,313,720,947 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 35.73, revenue per share of $111.03
and a 4.72% return on assets.

Thermo Fisher Scientific Inc. is engaged in serving science. The Company operates
through four segments. Life Sciences Solutions segment provides a portfolio of reagents,
instruments and consumables used in biological and medical research, discovery and
production of new drugs and vaccines, as well as diagnosis of infection and disease.
Analytical Instruments segment provides an offering of instruments and the supporting
consumables, software and services that are used for a range of applications. Specialty
Diagnostics segment offers a range of diagnostic test kits, reagents, culture media,
instruments and associated products to serve customers in healthcare, clinical, 
pharmaceutical, industrial and food safety laboratories. Laboratory Products and
Biopharma Services segment offers virtually everything needed for the laboratory.
Its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher 
Scientific, Unity Lab Services, Patheon and PPD.

Share on:
